• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SOFRADIM PRODUCTION SAS PARIETEX; MESH, SURGICAL, POLYMERIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SOFRADIM PRODUCTION SAS PARIETEX; MESH, SURGICAL, POLYMERIC Back to Search Results
Model Number PCOPM20
Medical Device Problem Codes Adverse Event Without Identified Device or Use Problem (2993); Patient Device Interaction Problem (4001)
Health Effect - Clinical Codes Abdominal Pain (1685); Adhesion(s) (1695); Bacterial Infection (1735); Erosion (1750); Dehydration (1807); Purulent Discharge (1812); Fistula (1862); Foreign Body Reaction (1868); Low Blood Pressure/ Hypotension (1914); Hypovolemic Shock (1917); Unspecified Infection (1930); Inflammation (1932); Liver Damage/Dysfunction (1954); Nausea (1970); Pain (1994); Renal Failure (2041); Scar Tissue (2060); Tachycardia (2095); Vomiting (2144); Electrolyte Imbalance (2196); Hernia (2240); Stenosis (2263); Obstruction/Occlusion (2422); Ascites (2596); Abdominal Distention (2601); Fluid Discharge (2686); Constipation (3274); Hyponatremia (4494); Renal Impairment (4499); Unspecified Tissue Injury (4559); Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available (4581); Sleepiness/Drowsiness/Somnolence (4850)
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of a hernia.It was reported that after implant, the patient experienced adhesions and recurrence.Post-operative patient treatment included revision surgery.It was noted that during implant procedure the mesh was cut through.
 
Additional Manufacturer Narrative
Additional information: a3a, a4, b5, b7, d6b, g1, h4, h6 (ime, imf, device codes).Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event or Problem Description
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of a hernia.It was reported that after implant, the patient experienced adhesions, recurrence, enterotomy, mesh erosion, pain, infection, inflammation, obstructions, scar tissue, enterotomy, and succus.Post-operative patient treatment included revision surgery, gore-tex patch repair of hernia, cholecystectomy, removal of mesh, repair of enterotomy caused by mesh erosion, repair of ileal conduit opening, exploratory laparotomy, lysis of adhesions, succus removed from bowel, and medication.It was noted that during implant procedure the mesh was cut through.
 
Event or Problem Description
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of a hernia.It was reported that after implant, the patient experienced adhesions, recurrence, mesh erosion, pain, infection, inflammation, obstructions, scar tissue, enterotomy, succus, labs abnormal for wbc; h & h; electrolyte derangement; coagulopathy; elevated creatinine (renal impairment); blood protein; high liver enzymes (liver damage/dysfunction), foreign body reaction, bacterial infection, hyponatremia, large fluid collection, air collection, acute kidney injury, abdominal pain, vomiting, ileus, nausea, acute renal failure, fistulous connection, urinoma, stenotic region, area of compromised tissue, systemic inflammatory response, cloudy foul smelling drainage, tachycardia, fevers, yellow drainage that looks like stool, purulent exudate, distention, constipation, dehydration, hypovolemic shock, low blood pressure, somnolence, & abdominal incisional wounds.Post-operative patient treatment included revision surgery, gore-tex patch repair of hernia, cholecystectomy, repair of enterotomy caused by mesh erosion, repair of ileal conduit opening, exploratory laparotomy, lysis of adhesions, succus removed from bowel, medication, mesh revision, removal of mesh, hospitalization, ct scan, cat scan, ng tube, iv hydration, symptomatic relief, bowel rest, use of drains, looposcopy, loopgram, foley catheter placement, iv antibiotics, drain management, urology consult, removal of tacks, icu, electrolyte repletion, lower abdominal wound care, reduction of hernia, & primary repair of hernia.
 
Additional Manufacturer Narrative
Additional info: a5b, b2, b5, b6, b7, d4 (unique identifier (udi) #), g1, h6 (patient codes, ime e2402: labs abnormal for wbc; h & h; coagulopathy; blood protein, air collection, ileus), & additional codes.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PARIETEX
Common Device Name
MESH, SURGICAL, POLYMERIC
Manufacturer (Section D)
SOFRADIM PRODUCTION SAS
116 avenue du formans
trevoux 01600
FR  01600
Manufacturer (Section G)
SOFRADIM PRODUCTION SAS
116 avenue du formans
trevoux 01600
FR   01600
Manufacturer Contact
mike bocchino
5920 longbow drive
8200 coral sea st ne
mounds view,mn, CO 55112
8006464633
MDR Report Key11846123
Report Number9615742-2021-01267
Device Sequence Number19639382
Product Code FTL
UDI-Device Identifier10884521177789
UDI-Public(01)10884521177789(17)140228(10)PJC00623
Combination Product (Y/N)N
Initial Reporter StateMA
Initial Reporter CountryUS
PMA/510(K) Number
K081126
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2013
Device Explanted Year2014
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Consumer
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 08/28/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date02/28/2014
Device Model NumberPCOPM20
Device Catalogue NumberPCOPM20
Device Lot NumberPJC00623
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/28/2021
Supplement Date Received by Manufacturer01/22/2025
08/13/2025
Initial Report FDA Received Date05/18/2021
Supplement Report FDA Received Date01/27/2025
08/28/2025
Date Device Manufactured03/31/2009
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention; Hospitalization; Life Threatening;
Patient SexMale
Patient Weight98 KG
Patient RaceWhite
-
-